🔎 Trials Near Me

Beranda › Neuroblastoma › Alabama › Birmingham

Uji klinis Neuroblastoma di Birmingham, AL

8 studi untuk Neuroblastoma mencari peserta di lokasi sekitar Birmingham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Menerima pesertaFase 3
  • Children's Hospital of Alabama, Birmingham
Hingga usia 30 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Menerima pesertaFase 2
  • University of Alabama/Children's of Alabama, Birmingham
Hingga usia 22 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Menerima pesertaFase 1/2
  • University of Alabama/Children's of Alabama, Birmingham
Hingga usia 26 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Menerima pesertaFase 1/2
  • University of Alabama/Children's of Alabama, Birmingham
Hingga usia 30 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06541262

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Menerima pesertaFase 3
  • Children's Hospital of Alabama, Birmingham
365 Days – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Menerima pesertaFase 1/2
  • Children's Hospital of Alabama, Birmingham
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Menerima pesertaFase 2
  • University of Alabama/Children's of Alabama, Birmingham
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05489887

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Menerima pesertaFase 2
  • Children's Hospital of Alabama/UAB, Birmingham
18 Months – 40 Years · Semua jenis kelamin · Diperbarui 12 Agu 2025 · NCT05135975

Uji klinis Neuroblastoma di kota lain

Studi lain di Birmingham

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.